LD-2 disclosure · Registration - Amendment
HORIZON PHARMA USA, INC.
Coverage · Registration amendment — updates registrant or client details already on file; not a periodic activity report.
Client
- Name
- HORIZON PHARMA USA, INC.
- Description
- Biopharmaceutical Development
- Location
- Illinois · United States of America
Registrant
- Description
- Government Affairs Consulting Firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Issues related to orphan drugs and the value of innovative medicines. March 2016 CMS proposed rule implementing a new Part B drug payment model. H.R. 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
LobbyistsDARREN WILLCOX
Covered position (DARREN WILLCOX): Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director.